Point72 Hong Kong’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-6,200
Closed -$189K – 545
2024
Q4
$189K Buy
+6,200
New +$174K 0.01% 286
2024
Q3
– Sell
-27,934
Closed -$807K – 541
2024
Q2
$807K Buy
+27,934
New +$650K 0.05% 213
2024
Q1
– Sell
-17,743
Closed -$480K – 642
2023
Q4
$480K Buy
+17,743
New +$465K 0.03% 356
2021
Q3
– Sell
-14,783
Closed -$1.84M – 2161
2021
Q2
$1.84M Buy
+14,783
New +$1.99M 0.06% 457
2019
Q3
– Sell
-32
Closed -$3K – 1137
2019
Q2
$3K Buy
+32
New +$2.44K ﹤0.01% 965

Other funds holding GH

Point72 Hong Kong's GH Position: Q1 2025 in Review

Point72 Hong Kong sold out of Guardant Health (GH) in Q1 2025, closing a stake of 6,200 shares — an estimated $189K sold.

Point72 Hong Kong first reported a position in GH in Q2 2019 and held it in 5 quarters. The position peaked at $1.84M in Q2 2021. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Point72 Hong Kong reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 6,200 Guardant Health shares in Q1 2025, an estimated $189K.
  • Point72 Hong Kong first reported a position in Guardant Health in Q2 2019 and held it in 5 quarters.
  • Point72 Hong Kong's Guardant Health position peaked at $1.84M in Q2 2021.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Point72 Hong Kong's 13F filing for Q1 2025, filed 15 May 2025.